OS Therapies IncorporatedOSTXNYSE
Loading
Year-over-year SG&A expense growth
Percentile
P46
Within normal range
vs 2Y Ago
0x
Contraction
Streak
1 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q3 2025 | 33.56% |
| Q2 2025 | -36.61% |
| Q1 2025 | 76.07% |
| Q4 2024 | 70.79% |
| Q3 2024 | 220.22% |
| Q2 2024 | 42.77% |
| Q1 2024 | 102.00% |
| Q4 2023 | -20.76% |
| Q3 2023 | 31997.68% |
| Q2 2023 | 77.56% |
| Q1 2023 | -54.21% |
| Q4 2022 | 0.00% |
| Q1 2022 | -63.37% |
| Q4 2021 | 0.00% |